lentivirus-based cell therapy (Intas Pharmaceuticals)

N/A

Report date: 2025/01/26 19:16:22

Base Information

Drug Namelentivirus-based cell therapy (Intas Pharmaceuticals)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionHemoglobin beta chain stimulants
TargetsHemoglobin beta chain
Therapy Area/IndicationsThalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntas Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIntas Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsThalassemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A